SK bioscience Co.,Ltd. 302440.KS Stock
SK bioscience Co.,Ltd. Price Chart
SK bioscience Co.,Ltd. 302440.KS Financial and Trading Overview
SK bioscience Co.,Ltd. stock price | 59200 KRW |
Previous Close | 78500 KRW |
Open | 78700 KRW |
Bid | 80800 KRW x N/A |
Ask | 80900 KRW x N/A |
Day's Range | 78600 - 81300 KRW |
52 Week Range | 65200 - 156500 KRW |
Volume | 402.32K KRW |
Avg. Volume | 420.3K KRW |
Market Cap | 6.21T KRW |
Beta (5Y Monthly) | 1.549588 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 78750 KRW |
302440.KS Valuation Measures
Enterprise Value | 4.85T KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | 8.27 |
Price/Sales (ttm) | 8.095874 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 6.326 |
Enterprise Value/EBITDA | 12.616 |
Trading Information
SK bioscience Co.,Ltd. Stock Price History
Beta (5Y Monthly) | 1.549588 |
52-Week Change | -24.51% |
S&P500 52-Week Change | 20.43% |
52 Week High | 156500 KRW |
52 Week Low | 65200 KRW |
50-Day Moving Average | 77706 KRW |
200-Day Moving Average | 79875 KRW |
302440.KS Share Statistics
Avg. Volume (3 month) | 420.3K KRW |
Avg. Daily Volume (10-Days) | 244.6K KRW |
Shares Outstanding | 76.78M |
Float | 23.73M |
Short Ratio | N/A |
% Held by Insiders | 69.14% |
% Held by Institutions | 4.59% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 36.32% |
Operating Margin (ttm) | 46.95% |
Gross Margin | 61.50% |
EBITDA Margin | 50.13% |
Management Effectiveness
Return on Assets (ttm) | 11.20% |
Return on Equity (ttm) | 17.81% |
Income Statement
Revenue (ttm) | 767.28B KRW |
Revenue Per Share (ttm) | 10011.25 KRW |
Quarterly Revenue Growth (yoy) | -58.79% |
Gross Profit (ttm) | 570.03B KRW |
EBITDA | 384.71B KRW |
Net Income Avi to Common (ttm) | 278.68B KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | -72.79% |
Balance Sheet
Total Cash (mrq) | 1.46T KRW |
Total Cash Per Share (mrq) | 19058.55 KRW |
Total Debt (mrq) | 127.45B KRW |
Total Debt/Equity (mrq) | 7.46 KRW |
Current Ratio (mrq) | 4.891 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | 168.91B KRW |
Levered Free Cash Flow (ttm) | 37.34B KRW |
Profile of SK bioscience Co.,Ltd.
Country | South Korea |
State | N/A |
City | Seongnam-si |
Address | 310, Pangyo-ro |
ZIP | 13494 |
Phone | 82 2 2008 2200 |
Website | https://www.skbioscience.co.kr |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the development of oral rotavirus vaccine that has completed phase 2 clinical trial; cervical cancer vaccine, which has completed phase 2 clinical trial; rotavirus vaccine that is in phase 3 clinical trial in Africa; typhoid conjugate vaccine; and Corona 19 vaccine that is in phase 1 and phase 1/2 clinical trials; and low-cost pneumococcal vaccine, which has completed phase 2 clinical trial and next-generation pneumococcal vaccine that is in phase 2 clinical trial in the United States. SK bioscience Co.,Ltd. was founded in 2018 and is based in Seongnam-si, South Korea.
Q&A For SK bioscience Co.,Ltd. Stock
What is a current 302440.KS stock price?
SK bioscience Co.,Ltd. 302440.KS stock price today per share is 59200 KRW.
How to purchase SK bioscience Co.,Ltd. stock?
You can buy 302440.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for SK bioscience Co.,Ltd.?
The stock symbol or ticker of SK bioscience Co.,Ltd. is 302440.KS.
Which industry does the SK bioscience Co.,Ltd. company belong to?
The SK bioscience Co.,Ltd. industry is Biotechnology.
How many shares does SK bioscience Co.,Ltd. have in circulation?
The max supply of SK bioscience Co.,Ltd. shares is 76.83M.
What is SK bioscience Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
SK bioscience Co.,Ltd. PE Ratio is now.
What was SK bioscience Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
SK bioscience Co.,Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the SK bioscience Co.,Ltd. company belong to?
The SK bioscience Co.,Ltd. sector is Healthcare.